ALC

ASSISTED LIVING CONCEPTS INC NEW CL A COM STK (NV)
ALC

Delisted

ALC was delisted on the 11th of July, 2013.

Back to rankings
Healthcare Medical Care Facilities

Financial journalist opinion

Neutral
Business Wire
3 days ago
Alcon to Present at 2025 Baird Global Healthcare Conference
GENEVA--(BUSINESS WIRE)--Alcon to Present at 2025 Baird Global Healthcare Conference.
Alcon to Present at 2025 Baird Global Healthcare Conference
Neutral
Business Wire
3 days ago
Alcon to Present at 2025 Baird Global Healthcare Conference
GENEVA--(BUSINESS WIRE)--Alcon to Present at 2025 Baird Global Healthcare Conference.
Alcon to Present at 2025 Baird Global Healthcare Conference
Negative
Benzinga
7 days ago
Trouble Ahead for Alcon Shares
Alcon Inc. is showing clear signs of weakness on its weekly chart. The stock has entered Phase 8 of its 18-phase Adhishthana cycle, and a critical breakdown from its Cakra formation has triggered what the framework calls a Move of Pralay, a bearish development that often carries multi-year implications.
Trouble Ahead for Alcon Shares
Negative
Zacks Investment Research
8 days ago
Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges
ALC's Q2 earnings top estimates but revenues fall short, sending shares down more than 10% as margins tightened and 2025 sales outlook narrowed.
Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges
Negative
Benzinga
8 days ago
These Analysts Slash Their Forecasts On Alcon After Q2 Earnings
Alcon Inc ALC posted better-than-expected earnings for the second quarter and cut its 2025 outlook late on Tuesday, citing increased tariff impact.
These Analysts Slash Their Forecasts On Alcon After Q2 Earnings
Neutral
Seeking Alpha
8 days ago
Alcon Inc. (ALC) Q2 2025 Earnings Call Transcript
Alcon Inc. (NYSE:ALC ) Q2 2025 Earnings Conference Call August 20, 2025 8:00 AM ET Call Participants Daniel Cravens - Vice President of Investor Relations David J. Endicott - CEO & Director Timothy C.
Alcon Inc. (ALC) Q2 2025 Earnings Call Transcript
Positive
Seeking Alpha
9 days ago
Alcon: More Than Meets The Eye
Alcon remains a leader in eye care, benefiting from strong market positioning and long-term industry tailwinds like aging populations and technological advances. Recent M&A activity, including the STAAR Surgical acquisition, enhances long-term growth but pressures near-term earnings and raises valuation concerns. Despite solid sales growth and manageable debt, shares trade at a demanding 29-30x earnings multiple, which I view as fully valued given current growth rates.
Alcon: More Than Meets The Eye
Negative
Benzinga
9 days ago
La-Z-Boy Posts Downbeat Q1 Results, Joins James Hardie Industries, Alcon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the S&P 500 futures falling around 0.1% on Wednesday.
La-Z-Boy Posts Downbeat Q1 Results, Joins James Hardie Industries, Alcon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Negative
WSJ
9 days ago
Alcon Shares Fall After Guidance Trim on U.S. Trade Tariff Hit
The company said it expects a $100 million hit from tariffs this year.
Alcon Shares Fall After Guidance Trim on U.S. Trade Tariff Hit
Negative
Reuters
9 days ago
Alcon shares fall after it cuts guidance and warns of tariff impact
Shares in Alcon fell as much as 11.6% on Wednesday after the Swiss-American eye care group cut its 2025 sales outlook late on Tuesday flagging the impact of U.S. tariffs.
Alcon shares fall after it cuts guidance and warns of tariff impact
See News Rankings
Charts implemented using Lightweight Charts™